Clinical Hematology International (Jan 2020)

Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma

  • Kristian T. Andersen,
  • Maja Hinge,
  • Agoston Gyula Szabo,
  • Erik Segel,
  • Tina Ormstrup,
  • Paw C. Holdgaard,
  • Niels Pallisgaard,
  • Gitte Kerndrup,
  • Torben Plesner

DOI
https://doi.org/10.2991/chi.d.200116.001
Journal volume & issue
Vol. 2, no. 1

Abstract

Read online

No abstracts available.

Keywords